Global Clinical Biomarker Testing Market By Services (Biomarker Assay Development & Validation, Flow Cytometry and Others) By Applications (Drug Discovery, Nutrigenomics, Toxicology Testing, Personalized Medicine and Functional Genomics) By Disease Types (Cancer, Metabolism, Infectious Disease, Cardiology, Neurology and Immunological Disease) By End-user (Pharmaceutical and Biotechnology Companies, Diagnostic Tool Companies, Healthcare IT/Big Data Companies, Clinical Laboratories, Academic and Research Institutes and CROS) and by Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033
Маrkеt Overview The Global Clinical Biomarker Testing Market size is expected to be worth around USD 1750.9 Million by 2033 from USD 873.6 Million in 2023, growing at a CAGR of 7.2% ...
